Sio Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Sio Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-369,494	Closed	-$5.31M	–	93
2019 Q3	$5.31M	Sell	369,494 -156,565	-30%	-$2.24M	1.71%	20
2019 Q2	$8.29M	Sell	526,059 -240,921	-31%	-$3.28M	2%	14
2019 Q1	$11.2M	Buy	766,980 +323,571	+73%	+$3.72M	3.03%	6
2018 Q4	$4.74M	Buy	+443,409	New	+$5.83M	1.73%	24

Other funds holding DRNA

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Sio Capital Management's DRNA Position: Q4 2019 in Review

Sio Capital Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2019, closing a stake of 369,494 shares — an estimated $5.31M sold.

Sio Capital Management first reported a position in DRNA in Q4 2018 and held it in 4 quarters. The position peaked at $11.2M in Q1 2019. 169 funds tracked by Wall St. Rank hold DRNA as of Q4 2019.

Sio Capital Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Sio Capital Management sold 369,494 Dicerna Pharmaceuticals, Inc. shares in Q4 2019, an estimated $5.31M.
Sio Capital Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2018 and held it in 4 quarters.
Sio Capital Management's Dicerna Pharmaceuticals, Inc. position peaked at $11.2M in Q1 2019.
169 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2019.

Based on Sio Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.